ZA974356B - Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid with choline, ethanolamine, serine or inositol. - Google Patents

Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid with choline, ethanolamine, serine or inositol.

Info

Publication number
ZA974356B
ZA974356B ZA9704356A ZA974356A ZA974356B ZA 974356 B ZA974356 B ZA 974356B ZA 9704356 A ZA9704356 A ZA 9704356A ZA 974356 A ZA974356 A ZA 974356A ZA 974356 B ZA974356 B ZA 974356B
Authority
ZA
South Africa
Prior art keywords
inositol
carrier
pharmaceutical compositions
compositions containing
choline
Prior art date
Application number
ZA9704356A
Other languages
English (en)
Inventor
Alberto Salini
Original Assignee
Flarer S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flarer S A filed Critical Flarer S A
Publication of ZA974356B publication Critical patent/ZA974356B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA9704356A 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid with choline, ethanolamine, serine or inositol. ZA974356B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI001010A IT1282733B1 (it) 1996-05-20 1996-05-20 Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico

Publications (1)

Publication Number Publication Date
ZA974356B true ZA974356B (en) 1998-01-14

Family

ID=11374287

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704356A ZA974356B (en) 1996-05-20 1997-05-20 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid with choline, ethanolamine, serine or inositol.

Country Status (12)

Country Link
US (1) US6194401B1 (xx)
EP (1) EP0901378B1 (xx)
JP (1) JP2000510857A (xx)
AT (1) ATE216254T1 (xx)
AU (1) AU709068B2 (xx)
CA (1) CA2255640A1 (xx)
DE (1) DE69712055D1 (xx)
IL (1) IL127154A0 (xx)
IT (1) IT1282733B1 (xx)
NZ (1) NZ332904A (xx)
WO (1) WO1997044053A1 (xx)
ZA (1) ZA974356B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
DE10038699A1 (de) * 2000-07-31 2002-02-14 Michael Sittinger Mittel zur Verringrung der Abstoßungsreaktionen bei Transplantaten
TWI366442B (en) * 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
KR100966627B1 (ko) * 2006-06-14 2010-06-29 주식회사 대웅제약 Ｌ-α-글리세로포스포릴 콜린의 제조방법
WO2009137066A1 (en) * 2008-05-08 2009-11-12 United Therapeutics Corporation Treprostinil monohydrate
US20110033527A1 (en) * 2009-06-02 2011-02-10 Nian Wu Opthalmic compositions of cyclosporin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515035A1 (fr) 1981-10-26 1983-04-29 Rhone Poulenc Sante Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
JPS5916818A (ja) 1982-07-20 1984-01-28 Shimizu Seiyaku Kk 経静脈投与用輸液剤
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
IT1265647B1 (it) 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
DE4338086A1 (de) * 1993-11-08 1995-05-11 Dietl Hans Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur oralen Applikation sowie Verfahren zu ihrer Herstellung
EP0697214A1 (en) * 1994-07-19 1996-02-21 Vestar, Inc. Liposomal cyclosporin pharmaceutical formulations

Also Published As

Publication number Publication date
US6194401B1 (en) 2001-02-27
NZ332904A (en) 2000-06-23
ITMI961010A0 (xx) 1996-05-20
AU709068B2 (en) 1999-08-19
WO1997044053A1 (en) 1997-11-27
AU3027697A (en) 1997-12-09
DE69712055D1 (de) 2002-05-23
CA2255640A1 (en) 1997-11-27
EP0901378B1 (en) 2002-04-17
IT1282733B1 (it) 1998-03-31
JP2000510857A (ja) 2000-08-22
ITMI961010A1 (it) 1997-11-20
ATE216254T1 (de) 2002-05-15
IL127154A0 (en) 1999-09-22
EP0901378A1 (en) 1999-03-17

Similar Documents

Publication Publication Date Title
ATE244015T1 (de) Formulierungen fuer faktor ix
UA70960C2 (uk) 4-амінозаміщені-2-заміщені-1,2,3,4-тетрагідрохіноліни як інгібітори протеїну, який переносить холестериловий етер
MY111841A (en) Injectable liposomal pharmaceutical preparations
AU1750097A (en) Highly concentrated, lyophilized, and liquid factor ix formulations
AU8495091A (en) Bisphosphonic acid derivatives as anti-arthritic agents
IL123010A (en) Pharmaceutical compositions of l-dopa ethyl ester
BG101893A (en) Nodulosporic acid derivatives
NO995928L (no) Alfa-1-antitrypsin-preparater samt fremgangsmåte ved fremstilling derav
HUP0002049A2 (hu) Tumornövekedés megakadályozására szolgáló eljárás izoprenoidok és sztatinok kombinációk alkalmazásával
PT831826E (pt) Composicao farmaceutica que inclui um inibidor de proteinase e um monoglicerideo
MX9701819A (es) Dihidrobenzofurano y compuestos relacionados, utiles como agentes antiiflamatorios.
ZA974356B (en) Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid with choline, ethanolamine, serine or inositol.
DE60214359D1 (en) Stickstoffbasierte camptothecin-derivate
DK0882136T3 (da) Fremgangsmåder til fremstilling af lysophosphatidylcholin
WO2001040177A3 (en) Esters of vitamin d3 and uses thereof
AU4916597A (en) Semi-synthetic studies toward didemnin analogues
AU5591900A (en) Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid
IL122942A0 (en) Esters of 1-beta-d-arabinofuranosylcytosine and pharmaceutical compositions containing them
MY126526A (en) Pharmaceutical formulations
AU3580995A (en) Derivatives of carbohydrates and compositions containing them
AR012989A1 (es) Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa.
DE69821240D1 (de) Phosphatidsäurenzusammenstellungen als immunomodulatoren
ES2172209T3 (es) Composiciones cosmeticas que contienen acido azelaico.
BG104452A (en) New derivatives of the methylenebisphosphonic acid
ES2170377T3 (es) Composicion que contiene quitosana.